Health Canada — Medical Devices · Canada · 2017-11-24 · Type III
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Archived by the issuing authority — kept for reference
Reported risk: A situation was identified where the cobas Liat analyzer was manufactured and distributed with 3 assay scripts pre-loaded on the instrument. One of the assay script (cobas Liat Strep A) is not yet licenced in Canada. However, there is no user-impact since the assay is not available in Canada and is not functional on the analyzer leading to no consequence on result reliability.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.